Literature DB >> 19536117

Direct-to-consumer genetic testing: failure is not an option.

R B Altman1.   

Abstract

Direct-to-consumer genetic testing is an unavoidable consequence of our ability to cheaply and accurately measure the genome. Some are troubled by the loss of control over how and when this information is disclosed to individuals, but it is difficult to imagine any way to prevent the wide availability of these data. Therefore, the key challenge is to set up social, educational, and technical means to support individuals who have access to their genome.

Entities:  

Mesh：

Year:  2009        PMID： 19536117      PMCID： PMC3086846          DOI： 10.1038/clpt.2009.63

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


  2 in total

1.  How (not) to protect genomic data privacy in a distributed network: using trail re-identification to evaluate and design anonymity protection systems.

Authors:  Bradley Malin; Latanya Sweeney
Journal:  J Biomed Inform       Date:  2004-06       Impact factor: 6.317

2.  Strategies for studying heterogeneous genetic traits in humans by using a linkage map of restriction fragment length polymorphisms.

Authors:  E S Lander; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205
  2 in total
  8 in total

Review 1.  A new era in clinical genetic testing for hypertrophic cardiomyopathy.

Authors:  Matthew Wheeler; Aleksandra Pavlovic; Emil DeGoma; Heidi Salisbury; Colleen Brown; Euan A Ashley
Journal:  J Cardiovasc Transl Res       Date:  2009-10-30       Impact factor: 4.132

2.  The evolution of personalized cancer genetic counseling in the era of personalized medicine.

Authors:  Hetal S Vig; Catharine Wang
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

3.  The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations.

Authors:  S W Gray; R C Hornik; J S Schwartz; K Armstrong
Journal:  Clin Genet       Date:  2011-11-02       Impact factor: 4.438

4.  Ethical issues raised by common copy number variants and single nucleotide polymorphisms of certain and uncertain significance in general medical practice.

Authors:  Arthur L Beaudet
Journal:  Genome Med       Date:  2010-07-17       Impact factor: 11.117

5.  Taxonomizing, sizing, and overcoming the incidentalome.

Authors:  Isaac S Kohane; Michael Hsing; Sek Won Kong
Journal:  Genet Med       Date:  2012-02-09       Impact factor: 8.822

6.  Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market.

Authors:  Pascal Borry; Martina C Cornel; Heidi C Howard
Journal:  J Community Genet       Date:  2010-10-08

7.  Which attributes of whole genome sequencing tests are most important to the general population? Results from a German preference study.

Authors:  Marika Plöthner; Katharina Schmidt; Clarissa Schips; Kathrin Damm
Journal:  Pharmgenomics Pers Med       Date:  2018-02-14

8.  Virtual research visits and direct-to-consumer genetic testing in Parkinson's disease.

Authors:  E Ray Dorsey; Kristin C Darwin; Samara Mohammed; Sean Donohue; Alyssa Tethal; Meredith A Achey; Susan Ward; Elaine Caughey; Emily D Conley; Nicholas Eriksson; Bernard Ravina
Journal:  Digit Health       Date:  2015-06-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.